Article

Interferometer wins design award

A proprietary interferometer (LipiView Ocular Surface Interferometer, TearScience, Inc.), has received the Medical Design Excellence Award from UBM Canon. The device provides eye-care practitioners with an in-office tear film procedure for dry eye patients that takes less than 5 minutes to perform.

Morrisville, NC-A proprietary interferometer (LipiView Ocular Surface Interferometer, TearScience Inc.), has received the Medical Design Excellence Award from UBM Canon.

The device provides eye-care practitioners with an in-office tear film procedure for patients with dry eye that takes less than 5 minutes to perform.

UBM Canon is a leading business-to-business media company dedicated to the advanced manufacturing sector. The Medical Design Excellence Awards competition recognizes contributions and advances in the design of medical products cleared for marketing by the FDA. Entries are evaluated on the basis of design and engineering features.

“We are honored to receive this distinguished award,” said Tim Willis, chief executive officer and co-founder for TearScience.  “Historically, physicians have had to rely on subjective tests to evaluate dry eye patients. Now, [the interferometer] provides a new, quantifiable alternative for evaluating patients’ tear films. When you consider just how thin a typical tear film is in nanometers, it’s amazing what the [interferometer] can do.”

The interferometer is approved in Canada and Europe; the device has not been cleared for use in the United States by the FDA.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.